In March, IVL signed a deal to acquire full shareholding in Montreal-based PTA manufacturer Cepsa Quimica SA.
That acquisition allowed IVL to expand its footprint in North America, as Cepsa is the only PTA facility on the continent.
Mr Lohia said IVL was still in talks to buy other assets over the next six months, most of them producers in Europe and North America.